News

Pharmabiz1h
Valneva SE, LimmaTech vaccinate first participant in phase 2 infant study of tetravalent Shigella vaccine candidate S4V2
Saint Herblain (France) & Schlieren (Zurich) Friday, April 11, 2025, 10:00 Hrs [IST] ...
Pharmabiz2h
GC Biopharma gets Korean Ministry of Food and Drug Safety approval for BARYTHRAX, the world’s first recombinant anthrax vaccine
Yong-in, South Korea Friday, April 11, 2025, 09:00 Hrs [IST] ...
Pharmabiz3h
Gujarat FDCA leads digital transformation with over 900 online licenses through mobile app: Dr Koshia
Gujarat FDCA leads digital transformation with over 900 online licenses through mobile app: Dr Koshia: Shardul Nautiyal, Mumbai Friday, April 11, 2025, 08:00 Hrs [IST] In a landma ...
Pharmabiz3h
Neurologists underscore need for advanced research to treat Parkinson’s Disease
Neurologists underscore need for advanced research to treat Parkinson’s Disease: Nandita Vijayasimha, Bengaluru Friday, April 11, 2025, 08:00 Hrs [IST] Neurologists in the count ...
Pharmabiz3h
CDSCO streamlines procedure for transfer of drugs manufactured in SEZ to DTA
CDSCO streamlines procedure for transfer of drugs manufactured in SEZ to DTA: Gireesh Babu, New Delhi Friday, April 11, 2025, 08:00 Hrs [IST] The central drug regulator has laid d ...
Pharmabiz3h
Experts concerned over promotional strategies of Eli Lilly for tirzepatide
Experts concerned over promotional strategies of Eli Lilly for tirzepatide: Shardul Nautiyal, Mumbai Friday, April 11, 2025, 08:00 Hrs [IST] As Mounjaro (tirzepatide), the blockbu ...
Pharmabiz3h
CDSCO automates generation of neutral code, MSC and NCC online
CDSCO automates generation of neutral code, MSC and NCC online: Gireesh Babu, New Delhi Friday, April 11, 2025, 08:00 Hrs [IST] The Central Drugs Standard Control Organisation (CD ...
Pharmabiz17h
argenx SE highlights VYVGART data setting new standard in efficacy and improved quality of life measures for patients with gMG and CIDP
Amsterdam, the Netherlands Thursday, April 10, 2025, 18:00 Hrs [IST] ...
Pharmabiz18h
US FDA inspects Science 37’s Direct-to-Patient Site for clinical research in phase 3 asthma trial; no objectionable conditions noted
US FDA inspects Science 37’s Direct-to-Patient Site for clinical research in phase 3 asthma trial; no objectionable conditions noted: Morrisville, N.C. Thursday, April 10, 2025, ...
Pharmabiz19h
OneSource’s unit 2 facility in Bengaluru gets Brazilian Health Regulatory Agency approval
OneSource’s unit 2 facility in Bengaluru gets Brazilian Health Regulatory Agency approval: Our Bureau, Mumbai Thursday, April 10, 2025, 15:50 Hrs [IST] OneSource Specialty Pharm ...
Pharmabiz20h
AstraZeneca to showcase innovation in infectious disease protection at ESCMID Global 2025
AstraZeneca to showcase innovation in infectious disease protection at ESCMID Global 2025: Cambridge, UK Thursday, April 10, 2025, 15:00 Hrs [IST] AstraZeneca will share new data ...
Pharmabiz22h
Avidity Biosciences receives Japan MHLW’s orphan drug status for delpacibart etedesiran to treat myotonic dystrophy type 1
Avidity Biosciences receives Japan MHLW’s orphan drug status for delpacibart etedesiran to treat myotonic dystrophy type 1: San Diego Thursday, April 10, 2025, 13:00 Hrs [IST] A ...